Gastric Acid Suppression May Promote Liver Injury

Share this content:
Gastric Acid Suppression May Promote Liver Injury
Gastric Acid Suppression May Promote Liver Injury

TUESDAY, Oct. 17, 2017 (HealthDay News) -- Based on data from mouse models and humans, a decrease in gastric acid secretion due to use of gastric acid suppressive medications seems to promote overgrowth of intestinal Enterococcus, which promotes liver disease, according to a study published online Oct. 10 in Nature Communications.

Noting that chronic liver disease is increasing in Western countries and liver cirrhosis is the 12th leading cause of death worldwide, Cristina Llorente, Ph.D., from the University of California San Diego in La Jolla, and colleagues examined the potential correlation between the increasing use of gastric acid suppressive medications and liver disease.

The researchers found that in mice, proton pump inhibitors promote progression of alcoholic liver disease, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis due to an elevation in the numbers of intestinal Enterococcus species. There was a correlation between translocating enterococci and hepatic inflammation/hepatocyte death. In mice, expansion of Enterococcus faecalis in the intestine was adequate to exacerbate ethanol-induced liver disease. Among alcohol-dependent patients, proton pump inhibitor use was associated with increased risk of developing alcoholic liver disease.

"Recent increases in the use of gastric acid-suppressive medications might contribute to the increasing incidence of chronic liver disease," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Ground Beef Recalled After E. Coli Outbreak

Ground Beef Recalled After <i>E. Coli</i> Outbreak

Beef was produced and packaged at Cargill Meat Solutions in Fort Morgan, Colo.

Prevalence of Alzheimer's, Related Dementia Set to Double

Prevalence of Alzheimer's, Related Dementia Set to Double

Alzheimer's disease and related dementias burden is expected to increase to 3.3 percent in 2060

Long-Term Outcomes of Breast Implants Explored

Long-Term Outcomes of Breast Implants Explored

Higher rates of Sjogren syndrome, scleroderma, RA, stillbirth, melanoma for silicone implants

is free, fast, and customized just for you!




Already a member?

Sign In Now »